Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020229660 - LYMPHOTOXIN ALPHA FOR USE IN THERAPY OF MYELOID LEUKEMIA

Publication Number WO/2020/229660
Publication Date 19.11.2020
International Application No. PCT/EP2020/063609
International Filing Date 15.05.2020
IPC
A61P 35/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
02specific for leukemia
A61K 38/18 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
18Growth factors; Growth regulators
CPC
A61K 38/1841
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
18Growth factors; Growth regulators
1841Transforming growth factor [TGF]
A61P 35/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
02specific for leukemia
Applicants
  • KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITÄT MÜNCHEN [DE]/[DE]
Inventors
  • JOST, Philipp J.
  • HÖCKENDORF, Ulrike
Agents
  • WINTER BRANDL FÜRNISS HÜBNER RÖSS KAISER POLTE - PARTNERSCHAFT MBB
Priority Data
19174964.716.05.2019EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) LYMPHOTOXIN ALPHA FOR USE IN THERAPY OF MYELOID LEUKEMIA
(FR) LYMPHOTOXINE ALPHA POUR L’UTILISATION DANS LA THÉRAPIE DE LA LEUCÉMIE MYÉLOÏDE
Abstract
(EN)
The present invention relates to a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms, a pharmaceutical composition comprising such a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms and a kit comprising such a polypeptide for use in the treatment of myeloid diseases or myeloid neoplasms.
(FR)
La présente invention concerne un polypeptide à utiliser dans le traitement des maladies myéloïdes ou des néoplasmes myéloïdes, une composition pharmaceutique comprenant un tel polypeptide pour l’utilisation dans le traitement des maladies myéloïdes ou des néoplasmes myéloïdes et un kit comprenant un tel polypeptide pour l’utilisation dans le traitement des maladies myéloïdes ou des néoplasmes myéloïdes.
Latest bibliographic data on file with the International Bureau